Hybrid lipids, peptides, and lymphocytes: new era in type 1 diabetes research
Abdel Rahim A. Hamad,1 Mohanraj Sadasivam,1 and Hamid Rabb2
1Department of Pathology and
2Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Address correspondence to: Abdel Rahim Hamad, Johns Hopkins University School of Medicine, Ross 66G, 720 Rutland Avenue, Baltimore Maryland 21205, USA. Phone: 410.614.3021; Email: ahamad@jhmi.edu.
Find articles by Hamad, A. in: JCI | PubMed | Google Scholar
1Department of Pathology and
2Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Address correspondence to: Abdel Rahim Hamad, Johns Hopkins University School of Medicine, Ross 66G, 720 Rutland Avenue, Baltimore Maryland 21205, USA. Phone: 410.614.3021; Email: ahamad@jhmi.edu.
Find articles by
Sadasivam, M.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Pathology and
2Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Address correspondence to: Abdel Rahim Hamad, Johns Hopkins University School of Medicine, Ross 66G, 720 Rutland Avenue, Baltimore Maryland 21205, USA. Phone: 410.614.3021; Email: ahamad@jhmi.edu.
Find articles by Rabb, H. in: JCI | PubMed | Google Scholar
First published August 5, 2019 - More info
J Clin Invest. 2019;129(9):3527–3529. https://doi.org/10.1172/JCI130313.
© 2019 American Society for Clinical Investigation
Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing β cells in islets of Langerhans. Many genetic and immunological insights into autoimmune disease pathogenesis were initially uncovered in the context of T1D and facilitated by preclinical studies using the nonobese diabetic (NOD) mouse model. Recently, the study of T1D has led to the discovery of fatty acid esters of hydroxyl fatty acids (FAHFAs), which are naturally occurring hybrid peptides that modulate inflammation and diabetes pathogenesis, and a hybrid lymphocyte that expresses both B and T cell receptors. Palmitic acid esters of hydroxy stearic acids (PAHSAs) are the most extensively studied FAHFA. In this issue of the JCI, Syed et al. have shown that PAHSAs both attenuate autoimmune responses and promote β cell survival in NOD mice. Given the lack of effective T1D therapies and the paucity of known side effects of PAHSAs, this lipid may have therapeutic potential for individuals at risk for or newly diagnosed with T1D.
- Purchase this article
- $10
- Purchasing this article will give you full access for the calendar year.
- Purchase Site Pass
- $25
- This will give you access to every article on the site for 24 hours.
- Online subscription
- $95
- Individual online subscriptions give you full online access for the calendar year.
- Individual online subscriptions ordered from September 1st on will receive access for the remainder of current year as well as for the full following year subscription term.
- Print subscription
- $830
- Individual print subscriptions give you the print journal and full online access for the year.
- JCI This Month subscription
- $125
- JCI This Month is a 16- to 20-page overview of the articles published each month
- Subscribing to JCI This Month also gives subscribers full online access for the calendar year.
- *Price outside U.S. and Canada: $225.
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)